News
Broad Institute will retain CRISPR patents, ruling says
The Broad Institute in Cambridge, Massachusetts, will retain potentially lucrative rights to a powerful gene-editing technique that could lead to major advances in medicine and agriculture, the federal Patent and Trademark Office ruled Wednesday.
News
CRISPR patent ruling has little impact in laboratory setting, MIT researchers say
Researchers maintained that the U.S. Patent Trial and Appeal Board’s Feb. 15 decision giving the Broad Institute the go-ahead on editing eukaryotic genomes with CRISPR had little impact on their research.